Return to Listing

1 result(s) for

PI Name Protocol # Title
Andy Chen STUDY00021065 A Phase 1/2 Open-Label, Multicenter Study of Lenzilumab and Axicabtagene Ciloleucel in Subjects with Relapsed or Refractory Large B-Cell Lymphoma (ZUMA-19)
 

You may also qualify for Phase 1 Program trials.

 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080